Clinical Trials Sponsored by Five Prime Therapeutics, Inc.
Total 11 results
-
Five Prime Therapeutics, Inc.TerminatedHealthy | Rheumatoid ArthritisHungary, Netherlands, Poland
-
Five Prime Therapeutics, Inc.CompletedAdvanced Solid TumorsKorea, Republic of, Australia
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Gastrointestinal Cancer | Gastrointestinal Cancer MetastaticUnited States
-
Five Prime Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Advanced Solid Tumors | Endometrial CancerUnited States, Korea, Republic of
-
Five Prime Therapeutics, Inc.No longer available
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the BladderKorea, Republic of, United States, Taiwan
-
Five Prime Therapeutics, Inc.CompletedTenosynovial Giant Cell Tumor | Pigmented Villonodular SynovitisUnited States, France, Netherlands, United Kingdom, Korea, Republic of, Poland
-
Five Prime Therapeutics, Inc.ParexelCompleted
-
Five Prime Therapeutics, Inc.Bristol-Myers SquibbCompletedRenal Cell Carcinoma | Head and Neck Cancer | Pancreatic Cancer | Ovarian Cancer | Malignant Glioma | Advanced Solid Tumors | Non-small Cell Lung CancerUnited States
-
Five Prime Therapeutics, Inc.Worldwide Clinical TrialsWithdrawnEndometrial Cancers With FGFR2 Mutations
-
Five Prime Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.CompletedGastric CancerUnited States, Spain, China, Italy, Korea, Republic of, Portugal, Taiwan, Japan, Turkey, France, Hungary, Thailand, Germany, Poland, Australia, Belgium, Romania, United Kingdom